Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing ceramic dual mobility inserts to standard polyethylene inserts in hip replacement surgery

Official title: A Randomized Controlled Trial Comparing Modular Dual Mobility Inserts With Ceramic Multilayer Coating Versus Standard Polyethylene Inserts for Primary Total Hip Arthroplasty (THA) in a Cementless Acetabular Cup

Run by Aesculap AG · NCT05547984 · Data updated 2026-11-12

This study is testing if new ceramic hip replacement inserts are safer and more effective than standard plastic inserts for people getting hip surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorAesculap AG
Industry-sponsored
Locations1 site (Ústí nad Labem)
StatusRecruiting
StartedNovember 21, 2022
Main results expectedSeptember 2027
Study endsAugust 2028
Registry record updatedDecember 16, 2025
Trial IDNCT05547984 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with primary coxarthrosis who are indicated for cementless total hip arthroplasty.

Probably not a fit

Patients with hip trauma, revision surgery, or other joint implants, as well as those with elevated metal ion levels or significant comorbidities, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial is a randomized controlled trial that aims to compare the effectiveness of modular dual mobility inserts with a ceramic multilayer coating against standard polyethylene inserts in patients undergoing primary total hip arthroplasty (THA). The study focuses on measuring cobalt and chromium ion serum levels to determine if they are comparable to those found in patients using standard metal-on-polyethylene articulations. The trial is designed to provide insights into the safety and efficacy of dual mobility systems in hip replacements, which have not been extensively compared to traditional methods in previous studies.

Why it matters

Potential benefit: If successful, this study could lead to improved outcomes and reduced metal ion exposure for patients undergoing hip replacement surgery.

How similar studies have gone: While there have been studies on metal ion release from modular dual mobility systems, this trial's direct comparison with standard articulation hip implants is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primary coxarthrosis patients indicated for cementless total hip arthroplasty
* Written informed patient consent

Exclusion Criteria:

* Hip trauma or revision surgery
* Rheumatoid or neurologic disease
* BMI \>35
* Ongoing oncologic therapy
* Preoperatively elevated Co or Cr serum levels \>1.0 µg/L
* Patients with other joint implants, or anticipated need for another joint replacement surgery within the study period
* Acetabular cup size \<52 expected
* Patients not able to mentally or physically comply with the study demands and follow-up visits
* Patients \<18 years at surgery
* Pregnancy

Where it's running

  • Masaryk Hospital
    Ústí nad Labem, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.